People: Vitrolife AB (VITRO.BE)
7.03EUR
24 May 2013
€-0.24 (-3.30%)
€7.30
€7.03
€7.03
€7.03
--
0
€7.52
€4.09
Axelsson, Thomas
Brief Biography
Mr. Thomas Axelsson has served as Chief Executive Officer (CEO) of Vitrolife AB since November 17, 2011. He was, among other things, CEO of Stille and Artema. Currently, he is Chairman of the Board of Directors at Dipylon Medical AB (previously CMA Microdialysis AB) and Airsonett AB, among others, as well as Member of the Board of Directors at MedCap AB.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Thomas Axelsson |
-- |
Mikael Engblom |
-- |
Magnus Nilsson |
3,304,000 |
Emma Sjoqvist |
-- |
Nils Sellbom |
-- |
Christer Silversand |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
